Glenmark Life Sciences (GLS.NSE) Q4 2024 Earnings

24OctConfirmed
Q1 2024
Q3 2024
Q4 2024
7.63
9.3
10.97
12.64

Details

Expected EPS
10.0363802
Actual EPS
7.6276489519999995
Surprise EPS
-2.41
Surprise Percent
+24%

Description

Glenmark Life Sciences (GLS.NSE) has reported earnings of 7.6276489519999995 per share for Q4 2024.

0 Comments

Share your thoughts